Can low-molecular-weight heparins improve outcome in patients with cancer? (Q34863116)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12234567%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

review article

1 reference

title

Can low-molecular-weight heparins improve outcome in patients with cancer? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12234567%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12234567%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

Ajay K Kakkar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12234567%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12234567%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

published in

Cancer Treatment Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12234567%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12234567%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12234567%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

151-155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12234567%20AND%20SRC:MED&resulttype=core&format=json

Prevention of venous thromboembolism

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900040-3

7 January 2021

Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900040-3

7 January 2021

Prevalence of pulmonary embolism at necropsy in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900040-3

7 January 2021

Fatal pulmonary embolism in cancer patients: is heparin prophylaxis justified?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900040-3

7 January 2021

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900040-3

7 January 2021

Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900040-3

7 January 2021

Tissue factor in cancer angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900040-3

7 January 2021

Role of tissue factor expression on tumour cell invasion and growth of experimental pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900040-3

7 January 2021

Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900040-3

7 January 2021

Effect of heparin on apoptosis in human nasopharyngeal carcinoma CNE2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900040-3

7 January 2021

10.1016/S0305-7372(02)00040-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12234567%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference